What is the normal folate (vitamin B9) level in an adult?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Normal Folate Level in Adults

Normal serum folate levels in adults range from approximately 10-45 nmol/L (4.4-20 ng/mL), while red blood cell (RBC) folate should be ≥340 nmol/L to indicate adequate long-term folate status. 1, 2

Serum vs. RBC Folate: Understanding the Difference

Serum/plasma folate reflects recent dietary intake and short-term folate status. The WHO-endorsed threshold for deficiency is <10 nmol/L 1. Using this cutoff, folate deficiency in the general adult population is relatively uncommon in countries with food fortification programs, with prevalence around 0.5-1% 3.

RBC folate provides a more reliable indicator of long-term tissue stores, reflecting folate status over the preceding 3 months during red cell formation. The WHO threshold for deficiency is <340 nmol/L 1. The ESPEN guideline specifically recommends using RBC folate for assessing long-term status 2.

Reference Ranges by Measurement Method

The 2022 ESPEN micronutrient guideline 2 and research data 3 establish these reference ranges:

  • Serum folate: 13.1-74.3 nmol/L (5th-95th percentiles) or 4.4-20 ng/mL
  • RBC folate: 347-1167 nmol/L (5th-95th percentiles)
  • Deficiency threshold (serum): <10 nmol/L or <4.4 ng/mL
  • Deficiency threshold (RBC): <340 nmol/L

A Norwegian population study 4 found similar ranges: 5.2-29.2 nmol/L for serum folate, with mean values around 11.9 nmol/L.

Clinical Interpretation Considerations

Supraphysiological levels (>45.3 nmol/L or >20 ng/mL) have become increasingly common in fortified populations, affecting up to 38% of elderly individuals post-fortification 3. While generally not harmful, levels >20 ng/mL warrant attention in elderly patients with concurrent low vitamin B12, as high folate can mask B12 deficiency-related megaloblastic anemia while allowing neurological damage to progress 5, 2.

Functional markers provide additional context. The intersection point where plasma homocysteine reaches its nadir occurs at serum folate of 10 nmol/L and RBC folate of 340 nmol/L, supporting these as optimal cutoffs for adequacy 6. However, homocysteine is also influenced by vitamins B2, B6, and B12 status, limiting its specificity 2.

Age-Specific Considerations

In elderly populations (>65 years), folate deficiency prevalence ranges from 7-12% when assessed by either serum or RBC folate 1. The institutionalized elderly show higher deficiency rates (5-68%) compared to community-dwelling individuals (0-23.5%) 1.

Common Pitfalls

  • Don't rely solely on serum folate for chronic conditions or suspected tissue depletion—RBC folate is superior for long-term assessment 2
  • Always check vitamin B12 concurrently in elderly patients with high folate levels to avoid missing B12 deficiency 5, 2
  • Consider supplement use when interpreting results, as it significantly elevates measured levels and may mask dietary inadequacy 1, 7
  • Microbiological assay using Lactobacillus rhamnosus remains the gold standard, though protein-binding assays and LC-MS methods are increasingly used 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.